North Macedonia

North Macedonia is rapidly emerging as a competitive hub for the pharmaceutical industry in Southeast Europe, anchored by a robust manufacturing base and a strategic focus on EU-GMP certified production.

The nation is best known for its long-standing expertise in generic drug manufacturing, with industry leaders like Alkaloid AD driving significant pharmaceutical exports to over 50 global markets.

Beyond traditional medicine, North Macedonia is expanding its biotechnology footprint, leveraging its status as a European biodiversity hotspot to fuel research into natural products and biosolutions.

The healthcare innovation landscape is supported by the prestigious Ss. Cyril and Methodius University in Skopje (UKIM), where specialized institutes focus on immunobiology and human genetics, bridging the gap between academic research and clinical application.

International investors are increasingly drawn to the country’s Technological Industrial Development Zones (TIDZ), which offer attractive incentives for medical device manufacturing and contract research organizations (CROs).

As the country aligns its regulatory frameworks with EU pharmaceutical acquis, it offers a high-compliance environment for regulatory affairs and quality assurance.

With a skilled workforce and growing investments in R&D infrastructure, North Macedonia is positioning itself as a cost-effective, high-quality destination for life sciences investment and clinical trial collaboration.